Enviornmental, Social & Governance

Dave-Quote-Bar

At Pacira, we believe that responsible corporate citizenship and sustainable performance are fundamental to the future health of our company.

Dave Stack | Chairman and CEO

Sustainability is an essential part of our company’s history and our long-term commitment to our stakeholders and communities. Our three non-opioid products, designed to improve patient outcomes through opioid-sparing strategies, and our unwavering commitment to helping address America’s opioid crisis, have allowed us to emerge as a leader in our industry. Tackling our nation’s complex opioid epidemic requires a multipronged strategy that challenges and transforms the way we think about and treat pain in the United States.

Sustainability is an essential part of our company’s history and our long-term commitment to our stakeholders and communities. Our three non-opioid products, designed to improve patient outcomes through opioid-sparing strategies, and our unwavering commitment to helping address America’s opioid crisis, have allowed us to emerge as a leader in our industry. Tackling our nation’s complex opioid epidemic requires a multipronged strategy that challenges and transforms the way we think about and treat pain in the United States. Education about the importance of non-opioid pain management is central to our mission to improve patient care. Our initiatives over the past decade have focused on redefining the role of opioids in pain management to a rescue medication, enabling surgical migration to 24-hour sites of care, and securing approval for the first and only FDA-approved long-acting local analgesic for children aged six and up.

At Pacira, we believe that responsible corporate citizenship and sustainable performance are vital to the health of our company. In 2021, we began to scrutinize our efforts to accelerate the pace of sustainable practices at our company by reinforcing our commitments to human and labor rights and increasing transparency of long-standing internal policies regarding bioethics, patient safety, and responsible marketing. The following are some of our key achievements:

  • In April 2021, we released our Global Human and Labor Rights Policy to increase transparency into our long-standing policies that protect and respect the rights of our employees, stakeholders, and communities. Concurrently, we updated our Supplier Code of Conduct to ensure that our suppliers are aligned with the both the spirit and requirements of our Global Human and Labor Rights Policy.
  • In June 2021, our board of directors formally assumed oversight of Sustainability. Our Nominating, Governance and Sustainability Committee is now tasked with creating, implementing, and supervising an industry-leading environmental, social and governance platform. We also updated our U.S. Code of Business Conduct and Ethics to reflect our commitment to Environmental, Social and Governance issues.
  • In April 2022, we released three policies to increase transparency into our long-standing commitment to Patient and Product Safety, Bioethics, and Responsible Marketing.

These developments have been embraced and we believe will create new and exciting opportunities for our company. While we are encouraged with our progress thus far, we know that there is still a lot of work to be done.

The innovative spirit and commitment to improving quality of life at Pacira has raised the level of expectations for the standard of care of over 10 million patients in the United States. Similarly, we are committed to upholding high standards while improving our position as a sustainable and responsible leader in our industry.

David Stack
Chief Executive Officer

Physician Payments Sunshine Act – Open Payments Database

In 2010, the United States established the Physician Payments Sunshine Act to increase the transparency of reporting financial relationships―including certain payments and items of value―between physicians and teaching hospitals and the manufacturers of pharmaceuticals, medical devices, and other biologicals that participate in U.S. federal healthcare programs. On an annual basis, this data must be reported to the Centers for Medicare and Medicaid Services (CMS).

To view our data reported to CMS, visit our Open Payments Database pages for our subsidiaries:

Pacira Pharmaceuticals, Inc.
Pacira CryoTech, Inc.